Dengue

Dengue
Name	Dengue
Field	Infectious disease, Virology, Tropical medicine
Symptoms	High fever, severe headache, retro-orbital pain, myalgia, arthralgia, rash, hemorrhage
Complications	Dengue hemorrhagic fever, dengue shock syndrome
Onset	4–10 days after bite
Duration	2–7 days (acute)
Causes	Flavivirus infection transmitted by Aedes mosquitoes
Diagnosis	Serology, PCR, NS1 antigen
Prevention	Vector control, vaccines in specific populations
Treatment	Supportive care, fluid management

Dengue is an acute febrile illness caused by a mosquito-borne flavivirus that circulates as four antigenically distinct serotypes. First well-documented in the 18th and 19th centuries, it is now endemic in tropical and subtropical regions and drives recurrent outbreaks affecting millions. The disease intersects with global travel, urbanization, and climate patterns, posing ongoing challenges to public health systems, clinical care, and vaccine policy.

Virology and Transmission

The causative agent is a single-stranded positive-sense RNA virus belonging to the family Flaviviridae and genus Flavivirus, with four principal serotypes historically labeled DENV-1 through DENV-4. Viral structure includes an envelope protein (E) that mediates cell entry and is the primary target of neutralizing antibodies described in studies by researchers affiliated with Pasteur Institute, Centers for Disease Control and Prevention, and World Health Organization. Transmission is primarily via the peridomestic mosquito species Aedes aegypti and secondarily Aedes albopictus, whose global spread has been documented by entomologists tied to institutions like London School of Hygiene and Tropical Medicine and Wageningen University. Human-to-mosquito-to-human cycles occur in urban, peri-urban, and rural ecologies; notable outbreaks have been traced through travel-associated importation linked to cities such as Miami, Bangkok, Rio de Janeiro, and Manila.

Signs and Symptoms

The typical incubation period ranges from 4 to 10 days after exposure, followed by abrupt onset of high fever, severe headache, retro-orbital pain, myalgia, and arthralgia, symptoms characterized in clinical reports from hospitals like Hospital das Clínicas (São Paulo), Tan Tock Seng Hospital, and All India Institute of Medical Sciences. Nonspecific features include nausea, vomiting, and a transient maculopapular rash that has been documented in case series from Singapore, Cebu, and Havana. Severe forms present with plasma leakage, mucosal bleeding, and shock, described in pediatric cohorts in Manila and adult series from Karachi. Laboratory abnormalities commonly include thrombocytopenia, hemoconcentration, and elevated liver enzymes noted in surveillance data from Thailand and Colombia.

Pathogenesis and Immune Response

Pathogenesis involves viral replication in dendritic cells and monocytes, with subsequent cytokine and complement activation—a mechanism elucidated in research labs at Harvard Medical School, University of Oxford, and Johns Hopkins University. A critical immunologic phenomenon is antibody-dependent enhancement (ADE), first inferred from epidemiologic observations during sequential infections in populations studied by investigators from University of Sao Paulo and Yale University, where non-neutralizing cross-reactive antibodies from a prior serotype can increase viral entry and replication. T cell responses and host genetic factors, including HLA associations noted in cohorts from Vietnam and Puerto Rico, modulate disease severity. Endothelial dysfunction, coagulopathy, and dysregulated immune mediators drive the plasma leakage and hemorrhagic manifestations described in clinical trials coordinated with International Vaccine Institute.

Diagnosis and Differential Diagnosis

Laboratory confirmation uses molecular diagnostics (RT-PCR), antigen detection (NS1), and serology (IgM/IgG), employed in reference centers like Institut Pasteur, CDC, and national public health laboratories in Brazil and India. Timing of specimen collection determines test sensitivity; RT-PCR is most sensitive early in the febrile phase, whereas IgM seroconversion is detected later, a pattern reflected in diagnostic algorithms from WHO and Pan American Health Organization. Differential diagnosis includes chikungunya, Zika, malaria, leptospirosis, typhoid fever, and other causes of acute febrile illness encountered in clinics at Makerere University Hospital, Kenya Medical Research Institute, and Singapore General Hospital.

Treatment and Management

There is no specific antiviral therapy approved for routine use; management is primarily supportive and guided by severity stratification protocols from World Health Organization and national ministries of health in Thailand and Brazil. Outpatient care focuses on oral hydration and analgesia with acetaminophen; nonsteroidal anti-inflammatory drugs are avoided due to bleeding risk, guidance endorsed by Royal College of Physicians advisories. Hospitalized patients require careful fluid resuscitation, monitoring of hematocrit and platelets, and critical care interventions for shock consistent with guidelines from American College of Critical Care Medicine and pediatric protocols from UNICEF-supported programs. Investigational antivirals and monoclonal antibodies have been evaluated in trials conducted by pharmaceutical firms collaborating with NIH and academic centers like Imperial College London.

Prevention and Control

Prevention emphasizes integrated vector management, including source reduction, insecticide application, and community engagement strategies advanced by WHO and nongovernmental partners such as Bill & Melinda Gates Foundation. Biological control measures, including release of Wolbachia-infected mosquitoes, have been piloted in cities like Cairns, Rio de Janeiro, and Yogyakarta under projects involving World Mosquito Program. Vaccination strategies include licensed vaccines deployed with age and serostatus considerations after large trials led by collaborations among Sanofi Pasteur, Butantan Institute, and public health agencies in Philippines and Thailand. Travel advisories and airport screening have been used during epidemics affecting hubs like Dubai and Paris.

Epidemiology and Public Health Impact

Dengue is endemic in more than 100 countries across Southeast Asia, the Western Pacific, the Americas, and parts of Africa, with estimated annual symptomatic cases in the tens of millions reported by WHO and modeled analyses from groups at Imperial College London and Johns Hopkins Bloomberg School of Public Health. Major urban outbreaks have stressed health systems in metropolises such as Manila, Lagos, Bangkok, and Fortaleza, prompting emergency responses coordinated by national disaster agencies and international partners including PAHO and UNICEF. Economic analyses by institutions like World Bank quantify direct medical costs and indirect productivity losses, while climate-related research from NASA and NOAA examines links between changing precipitation patterns and vector distribution. Continuous surveillance, vaccine policy refinement, and vector innovations remain central to reducing morbidity, mortality, and societal burden.

Category:Viral infections